AIMS: To determine the recurrence of pancreatitis and subsequent pancreatic function in patients who stop drinking after the first episode of alcohol-associated pancreatitis. METHODS: Of a total of 118 patients suffering from their first alcohol-associated pancreatitis, 18 (all men, age median 47 (27-71) years) met the inclusion criterion for abstinence during follow-up. The criterion for abstinence was alcohol consumption <24 g per 2 months (self-estimated), which is in line with questionnaires eliciting alcohol consumption and dependency (Alcohol Use Disorders Identification Test < 8 and Short Alcohol Dependence Data < 9). Recurrent attacks of acute pancreatitis were studied. Smoking, body mass index and laboratory tests detecting heavy consumption of alcohol were recorded. Blood and faecal tests were studied to assess endocrine and exocrine pancreatic function. RESULTS: During a mean follow-up time of 5.15 (1.83-9.13) years and a total of 92.7 patient-years, there were no recurrent attacks of acute pancreatitis among the 18 abstainers. Two patients had diabetes prior to and one was diagnosed immediately after the first episode of acute pancreatitis. One patient had impaired glucose metabolism at 2 years. Two patients had low insulin secretion in glucagon-C-peptide test, one at 4 years and the other at 5 years. Only one patient (6%) maintained low elastase-1 activity during the abstinence follow-up. Of the 100 non-abstainers, 34% had at least one recurrence during the follow-up. CONCLUSION: Regardless of the mediator mechanisms of acute alcoholic pancreatitis, abstinence after the first episode protects against recurrent attacks. Pancreatic dysfunction is also rare among abstinent patients.
AIMS: To determine the recurrence of pancreatitis and subsequent pancreatic function in patients who stop drinking after the first episode of alcohol-associated pancreatitis. METHODS: Of a total of 118 patients suffering from their first alcohol-associated pancreatitis, 18 (all men, age median 47 (27-71) years) met the inclusion criterion for abstinence during follow-up. The criterion for abstinence was alcohol consumption <24 g per 2 months (self-estimated), which is in line with questionnaires eliciting alcohol consumption and dependency (Alcohol Use Disorders Identification Test < 8 and Short Alcohol Dependence Data < 9). Recurrent attacks of acute pancreatitis were studied. Smoking, body mass index and laboratory tests detecting heavy consumption of alcohol were recorded. Blood and faecal tests were studied to assess endocrine and exocrine pancreatic function. RESULTS: During a mean follow-up time of 5.15 (1.83-9.13) years and a total of 92.7 patient-years, there were no recurrent attacks of acute pancreatitis among the 18 abstainers. Two patients had diabetes prior to and one was diagnosed immediately after the first episode of acute pancreatitis. One patient had impaired glucose metabolism at 2 years. Two patients had low insulin secretion in glucagon-C-peptide test, one at 4 years and the other at 5 years. Only one patient (6%) maintained low elastase-1 activity during the abstinence follow-up. Of the 100 non-abstainers, 34% had at least one recurrence during the follow-up. CONCLUSION: Regardless of the mediator mechanisms of acute alcoholic pancreatitis, abstinence after the first episode protects against recurrent attacks. Pancreatic dysfunction is also rare among abstinent patients.
Authors: Jussi Nikkola; Irina Rinta-Kiikka; Sari Räty; Johanna Laukkarinen; Riitta Lappalainen-Lehto; Satu Järvinen; Hanna Seppänen; Isto Nordback; Juhani Sand Journal: J Gastrointest Surg Date: 2013-09-04 Impact factor: 3.452
Authors: C Mel Wilcox; Bimaljit S Sandhu; Vikesh Singh; Andres Gelrud; Judah N Abberbock; Stuart Sherman; Gregory A Cote; Samer Al-Kaade; Michelle A Anderson; Timothy B Gardner; Michele D Lewis; Christopher E Forsmark; Nalini M Guda; Joseph Romagnuolo; John Baillie; Stephen T Amann; Thiruvengadam Muniraj; Gong Tang; Darwin L Conwell; Peter A Banks; Randall E Brand; Adam Slivka; David Whitcomb; Dhiraj Yadav Journal: Am J Gastroenterol Date: 2016-08-16 Impact factor: 10.864
Authors: Wei Huang; Daniel de la Iglesia-García; Iria Baston-Rey; Cristina Calviño-Suarez; Jose Lariño-Noia; Julio Iglesias-Garcia; Na Shi; Xiaoying Zhang; Wenhao Cai; Lihui Deng; Danielle Moore; Vikesh K Singh; Qing Xia; John A Windsor; J Enrique Domínguez-Muñoz; Robert Sutton Journal: Dig Dis Sci Date: 2019-06-04 Impact factor: 3.487
Authors: Andrea Párniczky; Péter Hegyi; Klementina Ocskay; Márk Félix Juhász; Nelli Farkas; Noémi Zádori; Lajos Szakó; Zsolt Szakács; Andrea Szentesi; Bálint Erőss; Emőke Miklós; Antal Zemplényi; Béla Birkás; Árpád Csathó; István Hartung; Tamás Nagy; László Czopf; Ferenc Izbéki; László Gajdán; Mária Papp; László Czakó; Dóra Illés; Marco V Marino; Antonello Mirabella; Ewa Małecka-Panas; Hubert Zatorski; Yaroslav Susak; Kristina Opalchuk; Gabriele Capurso; Laura Apadula; Cristian Gheorghe; Ionut Adrian Saizu; Ole H Petersen; Enrique de-Madaria; Jonas Rosendahl Journal: BMJ Open Date: 2022-01-04 Impact factor: 2.692